Oscar Health, Inc.
OSCR
$16.80
$1.388.95%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 48.46% | 54.48% | 56.76% | 51.39% | 45.79% |
Total Other Revenue | -7.19% | -12.34% | -3.64% | -9.26% | -38.23% |
Total Revenue | 48.29% | 54.26% | 56.54% | 51.12% | 45.19% |
Cost of Revenue | 57.70% | 57.44% | 57.96% | 49.77% | 40.41% |
Gross Profit | 15.18% | 42.91% | 51.12% | 56.36% | 64.94% |
SG&A Expenses | 27.91% | 29.74% | 23.13% | 35.32% | 43.47% |
Depreciation & Amortization | -5.91% | -7.45% | 4.73% | 33.56% | 135.07% |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 51.12% | 51.10% | 49.55% | 41.87% | 32.32% |
Operating Income | -360.76% | 783.74% | 124.30% | 119.04% | 111.11% |
Income Before Tax | -730.66% | 379.53% | 112.51% | 110.60% | 105.06% |
Income Tax Expenses | 62.52% | 737.99% | 121.77% | 103.93% | 571.58% |
Earnings from Continuing Operations | -980.17% | 332.12% | 109.65% | 108.51% | 103.84% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -442.45% | -678.85% | -414.18% | -208.22% | -111.76% |
Net Income | -988.48% | 330.15% | 109.39% | 108.35% | 103.83% |
EBIT | -360.76% | 783.74% | 124.30% | 119.04% | 111.11% |
EBITDA | -220.78% | 2,152.58% | 143.63% | 131.54% | 119.28% |
EPS Basic | -1,433.47% | 288.92% | 113.14% | 107.30% | 102.18% |
Normalized Basic EPS | -938.36% | 326.68% | 115.74% | 109.10% | 103.27% |
EPS Diluted | -600.63% | 153.07% | 93.26% | 96.38% | 94.29% |
Normalized Diluted EPS | -454.22% | 173.70% | 97.45% | 95.29% | 93.37% |
Average Basic Shares Outstanding | 8.46% | 8.91% | 8.45% | 7.51% | 6.48% |
Average Diluted Shares Outstanding | 0.46% | 14.31% | 22.85% | 22.11% | 21.24% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |